| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/25/2012 | CN101912355B Recombinant human interleukin-1 receptor antagonist in-situ gel |
| 07/25/2012 | CN101890155B Medicinal composition and application thereof |
| 07/25/2012 | CN101884785B Enzymolysis ovalbumin compound oral liquid |
| 07/25/2012 | CN101851280B Plectasin mature polypeptide dimer fusion protein and preparation method thereof |
| 07/25/2012 | CN101824071B Antioxidant peptide from collagen and application thereof |
| 07/25/2012 | CN101804199B Pharmaceutical composition used for alimentary canals and application thereof |
| 07/25/2012 | CN101797384B Tri-union compound immunopotentiator and method for preparing same |
| 07/25/2012 | CN101747411B Aminoacyl tryptophyl tryptophan tripeptide benzyl ester as well as preparation method and application thereof |
| 07/25/2012 | CN101732700B Health-care wine and preparation method thereof |
| 07/25/2012 | CN101724017B 4-nitro-L-phenylalanine dipeptide derivatives as well as preparation method and applications thereof |
| 07/25/2012 | CN101711874B Application of cell penetrating peptide Tat-mediated growth factor in transdermal transfer |
| 07/25/2012 | CN101703767B Preparation method of nibrio parahaemolyticus outer membrane protein VP2850and application of immunity protective function thereof |
| 07/25/2012 | CN101693016B Universal pharmaceutical formulation for recombined human serum albumin fusion proteins for injection |
| 07/25/2012 | CN101508722B Novel antihypertensive peptide and use thereof |
| 07/25/2012 | CN101492715B siRNA for suppressing human CSAG1 gene expression through RNA interference and uses of siRNA |
| 07/25/2012 | CN101492710B Uses of ZCCHC13 gene |
| 07/25/2012 | CN101456910B Wood frog antibiotic peptides and preparation technology and its application in antiviral drug |
| 07/25/2012 | CN101455404B Protein chewing tablet |
| 07/25/2012 | CN101397339B Method for removing/inactivating virus in glucoprotein |
| 07/25/2012 | CN101157725B Preparation method of human insulin analogue and usage thereof |
| 07/25/2012 | CN101002944B Conjugate of branched chair polymacrogol-interferon, and its preparing method |
| 07/24/2012 | US8227593 Modulation of forkhead box O1A expression |
| 07/24/2012 | US8227581 Modified α-galactosyl ceramides for staining and stimulating natural killer T cells |
| 07/24/2012 | US8227580 Human monoclonal antibodies to epidermal growth factor receptor |
| 07/24/2012 | US8227575 Cytokine zalpha11 ligand antibodies |
| 07/24/2012 | US8227574 Collagen materials, films and methods of making same |
| 07/24/2012 | US8227573 Utility of phylloplanins as antibiotics, selective fungicides and for enhancing microbial resistance in plants |
| 07/24/2012 | US8227570 Modified gherlin peptides |
| 07/24/2012 | US8227569 Immunomodulatory protein and useful embodiments thereof |
| 07/24/2012 | US8227471 Treating sexual desire disorders with flibanserin |
| 07/24/2012 | US8227441 Methods to increase or decrease bone density |
| 07/24/2012 | US8227439 Treatment of metastatic tumors |
| 07/24/2012 | US8227438 Suppressors of CpG oligonucleotides and methods of use |
| 07/24/2012 | US8227433 Use of inhibitors and antisense oligonucleotides of BTK for treating proliferative mastocytosis |
| 07/24/2012 | US8227424 Collagen peptide, dipeptide and malady inhibitor |
| 07/24/2012 | US8227423 Antibacterial peptide with activity against B. anthracis |
| 07/24/2012 | US8227422 Peptides and compounds that bind to a receptor |
| 07/24/2012 | US8227421 Fluorinated GHRH antagonists |
| 07/24/2012 | US8227420 Method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID |
| 07/24/2012 | US8227419 Method of treating conditions associated with airway tissue remodeling |
| 07/24/2012 | US8227418 Alpha-defensins as anthrax immunotherapeutics |
| 07/24/2012 | US8227417 HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants |
| 07/24/2012 | US8227415 Non-porous film for culturing cells |
| 07/24/2012 | US8227414 Highly potent full and partial agonists and antagonists of the nociceptin/orphanin FQ receptor |
| 07/24/2012 | US8227413 Compositions and methods for inducing angiogenesis |
| 07/24/2012 | US8227412 Bioactive parstatin peptides and methods of use |
| 07/24/2012 | US8227411 Peptide chain that has a minimum of three amino acid residues, has a maximum of about fifty amino acid residues, and binds a fibroblast growth factor receptor; treatment of emphysema, suppression of cardiac failure, control perfusion damage from myocardial infarction, accelerate bone fracture healing |
| 07/24/2012 | US8227410 Methods of stimulating wound healing by administration of vascular endothelial growth factor D (VEGF-D) |
| 07/24/2012 | US8227409 Diketopiperazine microparticles with defined isomer contents |
| 07/24/2012 | US8227408 Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology |
| 07/24/2012 | US8227407 Macrocyclic inhibitors of hepatitis C virus |
| 07/24/2012 | US8227406 Antimicrobial peptides |
| 07/24/2012 | US8227405 Fluorinated GHRH antagonists |
| 07/24/2012 | US8227404 Method of preventing acute or sub-acute hepatic failure in a subject by administering a soluble human tumor necrosis factor alpha fusion protein |
| 07/24/2012 | US8227403 A-β immunogenic peptide carrier conjugates and methods of producing same |
| 07/24/2012 | US8227402 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; copper binding protein; inhibit the development of premalignant lesions in mammalian tissue |
| 07/24/2012 | US8227212 Cell that expresses a sulfatase and a formylglycine generating enzyme |
| 07/24/2012 | US8227207 Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis |
| 07/24/2012 | US8227200 Methods for identifying kremen polypeptide binding partners |
| 07/24/2012 | US8226982 Inhalable powders comprising protein, phenylalanine, and other protein stabilizers |
| 07/24/2012 | US8226976 Method of using cell-free protein synthesis to produce a membrane protein |
| 07/24/2012 | US8226970 Non-woven fiber fabric |
| 07/24/2012 | US8226958 Modified SEB and prophylactics/remedies for immunopathy containing the same |
| 07/24/2012 | US8226955 Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes |
| 07/24/2012 | US8226950 Recombinant anti-VLA4 antibody molecules |
| 07/24/2012 | US8226947 Interleukin-10 antibodies |
| 07/24/2012 | US8226942 PDGF fusion proteins incorporated into fibrin foams |
| 07/24/2012 | US8226941 Methods of purifying chondroitinase and stable formulations thereof |
| 07/24/2012 | US8226940 Enhancing the effect of therapeutic proteins on the central nervous system |
| 07/24/2012 | US8226939 Antimicrobial peracid compositions with selected catalase enzymes and methods of use in aseptic packaging |
| 07/24/2012 | US8226935 ErbB2 and ErbB3 chimeric heteromultimer receptors |
| 07/24/2012 | US8226930 Synthetic MeCP2 sequence for protein substitution therapy |
| 07/24/2012 | US8226776 Treating protein-containing liquids |
| 07/24/2012 | CA2605923C Use of antagonists of oxytocin and/or vasopressin |
| 07/24/2012 | CA2566731C Methods of purifying chondroitinase and stable formulations thereof |
| 07/24/2012 | CA2536182C Macrocyclic peptides active against the hepatitis c virus |
| 07/24/2012 | CA2501738C Method of treating chronic pelvic pain syndrome by administration of chrorionic gonadotropin |
| 07/24/2012 | CA2490116C Acidic insulin preparations with improved stability |
| 07/24/2012 | CA2488167C Prodrugs of excitatory amino acids |
| 07/24/2012 | CA2486252C Methods for screening for agents that modulate hepatocellular carcinoma development |
| 07/24/2012 | CA2474243C Medical device for delivering biologically active material |
| 07/24/2012 | CA2471822C Cell-specific herpes simplex virus expression/replication vector comprising icp4 and human calponin gene promoter |
| 07/24/2012 | CA2458146C Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 07/24/2012 | CA2438334C Ocular tear growth factor-like protein |
| 07/24/2012 | CA2410887C Compounds for targeting endothelial cells, compositions containing the same and methods for their use |
| 07/24/2012 | CA2342289C Treatment of cervical cancer |
| 07/24/2012 | CA2315538C Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 07/19/2012 | WO2012097344A2 Metal abstraction peptide and uses thereof |
| 07/19/2012 | WO2012097261A2 Methods targeting mir-128 for regulating cholesterol/lipid metabolism |
| 07/19/2012 | WO2012097126A2 Il-25 treatment of obesity and metabolic disorders |
| 07/19/2012 | WO2012097123A2 New uses of cyclophilin inhibitors |
| 07/19/2012 | WO2012097093A2 Novel wnt compositions and therapeutic uses of such compositions |
| 07/19/2012 | WO2012097057A2 Methods, compositions and kits for modulating trans-differentiation of muscle satellite cells |
| 07/19/2012 | WO2012097019A1 Use of a vegf antagonist to treat angiogenic eye disorders |
| 07/19/2012 | WO2012096926A2 Method for delivering agents into cells using bacterial toxins |
| 07/19/2012 | WO2012096893A2 Antigen surrogates in autoimmune disease |
| 07/19/2012 | WO2012096870A1 Composition and method for treating cancer |
| 07/19/2012 | WO2012096697A1 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
| 07/19/2012 | WO2012096596A1 Antiviral agent |
| 07/19/2012 | WO2012096595A1 Palladium-copper catalysts for the homogeneous selective oxidation of thiol groups |